Dr. Leah Croll Pens Commentary for Medscape on Alzheimer’s Disease Medications Leqembi and Donanemab

Leah Croll, MD, Assistant Professor of Clinical Neurology at the Lewis Katz School of Medicine at Temple University, wrote a commentary for Medscape on Alzheimer’s disease medications Leqembi (approved by the U.S. Food and Drug Administration) and donanemab (awaiting FDA approval).